Braskem (BAK) Asset Writedowns and Impairment (2009 - 2025)

Braskem (BAK) has reported Asset Writedowns and Impairment for 12 consecutive years, with $193.7 million the latest figure, recorded in Q1 2025.

• Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $193.7 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $868.7 million (changed N/A YoY) and the FY2025 annual result came in at $3.3 million, down 77.7% from the prior year.
• Asset Writedowns and Impairment improved to $193.7 million in Q1 2025 per BAK's latest filing, from $4.9 million in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for BAK reached as high as $193.7 million in Q1 2025 and fell as low as $193.7 million in Q1 2025.